GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XTER:QIA) » Definitions » Cyclically Adjusted Price-to-FCF

Qiagen NV (XTER:QIA) Cyclically Adjusted Price-to-FCF : 29.22 (As of Jun. 05, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Qiagen NV's current share price is €40.325. Qiagen NV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €1.38. Qiagen NV's Cyclically Adjusted Price-to-FCF for today is 29.22.

The historical rank and industry rank for Qiagen NV's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XTER:QIA' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 25.34   Med: 44.94   Max: 80.62
Current: 30.25

During the past years, Qiagen NV's highest Cyclically Adjusted Price-to-FCF was 80.62. The lowest was 25.34. And the median was 44.94.

XTER:QIA's Cyclically Adjusted Price-to-FCF is ranked worse than
54.55% of 66 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.595 vs XTER:QIA: 30.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Qiagen NV's adjusted free cash flow per share data for the three months ended in Mar. 2025 was €0.401. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.38 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Qiagen NV Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Qiagen NV's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Cyclically Adjusted Price-to-FCF Chart

Qiagen NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.19 61.76 42.69 35.31 31.11

Qiagen NV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.69 30.22 32.59 31.11 26.57

Competitive Comparison of Qiagen NV's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Qiagen NV's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Cyclically Adjusted Price-to-FCF falls into.


;
;

Qiagen NV Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Qiagen NV's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=40.325/1.38
=29.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qiagen NV's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Qiagen NV's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.401/133.3300*133.3300
=0.401

Current CPI (Mar. 2025) = 133.3300.

Qiagen NV Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.166 100.230 0.221
201509 0.293 100.500 0.389
201512 0.186 99.730 0.249
201603 0.110 100.310 0.146
201606 0.289 100.260 0.384
201609 0.289 100.570 0.383
201612 0.309 100.710 0.409
201703 0.151 101.440 0.198
201706 0.153 101.370 0.201
201709 0.175 102.030 0.229
201712 0.167 101.970 0.218
201803 0.052 102.470 0.068
201806 0.333 103.100 0.431
201809 0.178 103.950 0.228
201812 0.252 103.970 0.323
201903 -0.434 105.370 -0.549
201906 0.187 105.840 0.236
201909 0.248 106.700 0.310
201912 0.248 106.800 0.310
202003 -0.050 106.850 -0.062
202006 0.051 107.510 0.063
202009 -0.192 107.880 -0.237
202012 0.754 107.850 0.932
202103 0.282 108.870 0.345
202106 0.418 109.670 0.508
202109 0.405 110.790 0.487
202112 0.585 114.010 0.684
202203 0.707 119.460 0.789
202206 0.586 119.050 0.656
202209 0.860 126.890 0.904
202212 0.301 124.940 0.321
202303 0.140 124.720 0.150
202306 0.331 125.830 0.351
202309 0.350 127.160 0.367
202312 0.405 126.450 0.427
202403 0.385 128.580 0.399
202406 0.550 129.910 0.564
202409 0.571 131.610 0.578
202412 0.604 131.630 0.612
202503 0.401 133.330 0.401

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Qiagen NV  (XTER:QIA) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Qiagen NV Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Qiagen NV Headlines

No Headlines